Navigation Links
Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
Date:6/9/2009

ion of fibroblast growth factor receptor 4 (FGFR4) lowered adiposity and improved insulin sensitivity in mice, indicating that FGFR4 plays a role in the regulation of energy expenditure and adiposity. Selective inhibition of FGFR4 with antisense drugs in peripheral tissues could be a unique therapeutic approach for the treatment of obesity and related metabolic disorders.

"We are looking forward to expanding our metabolic disease pipeline by adding antisense drugs to treat obesity, an area with great unmet need where our peripherally acting drugs could have significant therapeutic utility without the potential for central nervous system toxicities that plague many centrally acting anti-obesity drugs," continued Dr. Bhanot. "Obesity is just one example of the many therapeutic areas that are amendable to our antisense drug discovery efforts. We continue to expand our discovery efforts and broaden our drug pipeline to address new diseases within our core therapeutic programs in cardiovascular, metabolic and severe neurodegenerative diseases and cancer."

Including presentations highlighting SGLT2 and FGFR4, Isis and its collaborators presented a total of eight presentations (including three oral talks and two late-breaking posters) at this year's ADA conference. The additional presentations highlighted antisense inhibitors to a number of metabolic targets in a variety of animal species that reduced mRNA target levels in specific tissues and provided therapeutic benefit such as improved insulin sensitivity, reduced fat mass and body weight in various models of disease. Complete abstracts for the presentations can be found on the ADA Web site at www.diabetes.org.

    ISIS 388626, an SGLT2 Antisense Drug, Causes Robust and Sustained
    Glucosuria in Multiple Species and Is Safe and Well-Tolerated (Oral
    Presentation)
    Authors: S. Bhanot, S.F. Murray, S.L
'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
3. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
4. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
5. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
6. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
7. Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
8. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
9. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
11. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) today announced ... of 2013 on Monday, February 3, 2014. A press release ... of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... operating highlights and financial results for the fourth quarter and ...
(Date:1/14/2014)... -- Acumed,s new SLIC Screw System - a jointed ... place and insert the screw accurately - offers surgeons ... repair or reconstruction as it holds the bones reduced ... http://photos.prnewswire.com/prnh/20140114/MN45636 ) The SLIC Screw is ...
(Date:1/14/2014)... N.Y. , Jan. 14, 2014   Oligomerix, Inc. , ... modifying therapeutics for Alzheimer,s disease (AD) and related neurodegenerative ... to Valhalla, NY as of ... laboratory space at New York Medical College. ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
(Date:4/17/2014)... today in PLOS Pathogens , children who live ... can mount an immune response to infection with malaria ... of high fever and illness and partially control the ... may help researchers develop future interventions that prevent or ... Each year, approximately 200 million cases of malaria occur ...
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
(Date:4/17/2014)... NY In a review published in the April ... president of The Feinstein Institute for Medical Research, says ... medical community,s approach to treating sepsis, which ... Americans. , Sepsis occurs when molecules released into the ... throughout the body. Inflammation is necessary for maintaining good ...
(Date:4/17/2014)... has created a new technology for modifying human ... the body and selectively target cancer and other ... that monitor and modify human physiology is a ... existing technology enabled bioengineers to build such devices ... in a customized fashion. , "The project addressed ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... traces roots of the problem , , THURSDAY, June 19 ... the use of an oral rapid HIV test was ... Health and Mental Hygiene, which operates 10 sexually transmitted ... introduced on-site, rapid HIV testing of finger-stick, whole-blood specimens ...
... 2008) Health-care system constraints combined with a lack ... brokering which patients are in greatest need of hip ... Michael,s Hospital researcher funded by the Canadian Institutes of ... means not everyone who needs this surgery will actually ...
... Chief of Naval Research (CNR) Rear Admiral William E. Landay ... brought to the Office of Naval Research (ONR) during the ... at the Marriott Wardman Park Hotel in Washington, D.C. , ... and technology organization, recognized both inside and outside the Navy, ...
... AUBURN HILLS, Mich., June 19 ... software for the manufacturing,enterprise, today announced the ... Plexus Online to facilitate collaboration,coordination and information-sharing ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070627/CLW071LOGO ), ...
... As if the emotional and financial impact of ... health problems. H. James Wedner, M.D., professor of medicine ... at Washington University School of Medicine in St. Louis, ... are fertile grounds for mold growth, which can cause ...
... reap rewards for people with asthma, MS, scientists ... have uncovered cellular proteins that may be key to ... study. , The findings, performed so far only ... range of human diseases that are mediated by immune ...
Cached Medicine News:Health News:False Positives in Oral HIV Test Halt Use in NYC 2Health News:System constraints forcing Canadian physicians to become medical brokers in prioritizing 2Health News:ONR offers up to $1M for innovative science and technology ideas 2Health News:Plexus Online Enables Business-Government-Academic Collaboration for Advanced Technology Institute 2Health News:Plexus Online Enables Business-Government-Academic Collaboration for Advanced Technology Institute 3Health News:Plexus Online Enables Business-Government-Academic Collaboration for Advanced Technology Institute 4Health News:Allergy expert has advice for flood victims 2Health News:Allergy expert has advice for flood victims 3Health News:Autoimmune Disease Treatment May Not Dampen Immune System 2Health News:Autoimmune Disease Treatment May Not Dampen Immune System 3Health News:Autoimmune Disease Treatment May Not Dampen Immune System 4
HeartSpeed HB is the bi-plane cardiac system to meet interventional physicians' demands of Speedy and Simple operability on bi-plane cath lab with the latest dose reduction and top quality imaging ch...
Kit for the Preparation of Technetium Tc 99m Teboroxime...
Triangle shape (3.0mm long) Tip with Sliding Inner Shaft, Squeeze Activates Shaft to Punch; overall length 130mm, in stainless steel...
Blunt Tapered Tip in stainless steel....
Medicine Products: